- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech High Growth Potential Companies
Canadian Pharmaceuticals & Biotech High Growth Potential Companies
Results
9
Companies with a Future performance score of at least 3, ordered by Future performance score.
9 companies
Sernova Biotherapeutics
Market Cap: CA$55.8m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.17
7D
0%
1Y
-63.8%
Decibel Cannabis
Market Cap: CA$31.7m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.055
7D
0%
1Y
-60.7%
Planet 13 Holdings
Market Cap: CA$110.6m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.34
7D
13.3%
1Y
-62.6%
Knight Therapeutics
Market Cap: CA$556.4m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$5.59
7D
-1.8%
1Y
-3.0%
Medexus Pharmaceuticals
Market Cap: CA$68.4m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.12
7D
-2.3%
1Y
35.9%
Theratechnologies
Market Cap: CA$124.1m
A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.
TH
CA$2.70
7D
14.9%
1Y
50.0%
Curaleaf Holdings
Market Cap: CA$847.1m
Produces and distributes cannabis products in the United States and internationally.
CURA
CA$1.12
7D
9.8%
1Y
-83.4%
Rakovina Therapeutics
Market Cap: CA$7.7m
A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.
RKV
CA$0.055
7D
-26.7%
1Y
-38.9%
Green Thumb Industries
Market Cap: CA$1.7b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$7.02
7D
-2.6%
1Y
-59.1%